Structural peculiarities of a truncated Yκ(III) immunoglobulin light chain in myeloma with light chain deposition disease

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 357-361

  Decourt, C ^a   Cogne M ^a,b   Rocca, A ^c  

^a UNIVERSITY OF LIMOGES   (France)

^b INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

light chain deposition disease; V (III) subgroup chain

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; BONE MARROW; DNA PRIMERS; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; PARAPROTEINEMIAS; POLYMERASE CHAIN REACTION; PROTEIN SORTING SIGNALS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0029832842     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Preud'homme JL, Morel-Maroger L, Brouet JC et al. Synthesis of abnormal immunoglobulins in lymphophismatic disorders with visceral light chain deposition. Am J Med 1980; 69:703-10.
2. Preud'homme JL, Morel-Maroger L, Brouet JC et al. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol 1980; 42:545-53.
3. Ganeval D, Noël LH, Preud'homme JL et al. Light chain deposition disease; its relation with AL-type amyloidosis. Kidney Int 1984; 26:1 9.
4. Picken MM, Frangione B, Barlogie B et al. Light chain deposition disease derived from the κI light chain subgroup. Biochemical characterization. Am J Pathol 1989; 134: 749-54.
5. Bellotti V, Stoppini M, Merlini G, et al. Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. Biochem Biophys Acta 1991; 1097:177 82.
6. IV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest 1991; 87: 2186-90.
7. Cogné M, Silvain C, Khamlichi AA et al. Structurally abnormal immunoglobulins in human immunoproliferative disorders. Blood 1992; 79:2181-95.
8. Khamlichi AA, Aucouturier P, Silvain C et al. Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease. Clin Exp Immunol 1992; 87:122-6.
9. κI subgroup (ISE) in light chain deposition disease. Clin exp Immunol 1993;91:506-509.
10. Denoroy L, Déret S, Aucouturier P. Overrepresentation of the VκIV subgroup in light chain deposition disease. Immunol Letters 1994;42:63-66.
11. Preud'homme JL, Aucouturier P, Touchard G et al. Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations. Int J Immunopharmacol 1994; 16:425-31.
12. Leduc I, Preu'homme JL, Cogné M. Structure and expression of the mb-1 transcript in human lymphoid cells. Clin Exp Immunol 1992; 90:141-6.
13. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230:1350-4.
14. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-7.
15. Kabat EA, Wu TT, Perry HM et al. Human kappa light chains subgroup III. In: Sequences of proteins of immunological interest. Bethesda: US Dept of Health and Human Services, Public Health Service, NIH, 1991:118-23.
16. Hieter PA, Maizel JV, Leder P. Evolution of human immunoglobulin κ region genes. J Biol Chem 1982; 257:1516-20.
17. Schäble KF, Zachau HG. The variable genes of the human immunoglobulin κ locus. Biol Chem Hoppe-Seyler 1993; 374:1001-22.
18. Liu MF, Robbins DL, Crowley JJ et al. Characterization of four homologous L chain variable region genes that are related to 6B6·6 idiotype positive human rheumatoid factor L chains. J Immunol 1989; 142:688-94.
19. Huber C, Schäble KF, Huber E et al. The Vκ genes of the L regions and the repertoire of Vκ gene sequences in the human germline. Eur J Immunol 1993; 23:2868-75.
20. Von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 1983; 133:17-21.
21. Von Heijne G. The signal peptide. J Membr Biol 1990; 115:195-201.
22. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196:901-17.
23. Toft KG, Sletten K, Husby G. The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type λ). Biol Chem Hoppe-Seyler 1985; 366:617-25.
24. Tveteraas T, Sletten K, Westermark P. The amino acid sequence of a carbohydrate-containing immunoglobulin light-chain-type amyloid-fibril protein. Biochem J 1985; 232:183-90.
25. Holm E, Sletten K, Husby G. Structural studies of a carbohydrate-containing immunoglobulin-λ light-chain amyloid-fibril protein (AL) of variable subgroup III. Biochem J 1986; 239:545-51.
26. Brownlee M, Pongor S, Cerami A. Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen: role in the in situ formation of immune complexes. J Exp Med 1983; 158:1739-44.
27. Benson MD. Pathofibrillogenesis and amyloid proteins. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P, eds. Amyloid and amyloidosis. Dordrecht: Kluwer Academic Publishers, 1990:481-6.
28. Klein R, Jaenichen R, Zachau HG. Expressed human immunoglobulin κ genes and their hypermutation. Eur J Immunol 1993; 23:3248-71.
29. Preud'homme JL, Buxbaum JN, Scharff MD. Mutagenesis of mouse myeloma cells with Melphalan. Nature 1973; 245:320-2.